Streptococcus pneumoniae nasopharyngeal colonization in children in brasov, central romania: High antibiotic resistance and coverage by conjugate vaccines

Pediatric Infectious Disease Journal

Volumn 30, Issue 1, 2011, Pages 76-78

  Falup Pecurariu, Oana ^a   Bleotu, Laura ^a   Zavarache, Cristina ^a   Peled, Nechama ^b,c   Anton, Oana ^a   Robu, Michaela ^a   Falup Pecurariu, Cristian ^a   Rogozea, Liliana ^a   Porat, Nurith ^b,c   Greenberg, David ^b,c   Dagan, Ron ^b,c   Leibovitz, Eugene ^b,c  

^a TRANSILVANIA UNIVERSITY OF BRASOV   (Romania)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

children; conjugate vaccines; nasopharyngeal colonization; Romania; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CHILD; HUMAN; MAJOR CLINICAL STUDY; NASOPHARYNX; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; ROMANIA; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

EID: 78650792091     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181f42bb6     Document Type: Article

References (10)

1. Jacobs MR, Dagan R, Appelbaum PC, et al. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998;42:589-595. (Pubitemid 28114813)
2. Leibovitz E, Dragomir C, Sfartz S, et al. Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania. Intern J Infect Dis. 1999;3:211-215.
3. Porat N, Leibovitz E, Dagan R, et al. Molecular typing of Streptococcus pneumoniae in Northeastern Romania: unique clones of S. pneumoniae isolated from children hospitalized for infections and from healthy and human immunodeficiency virus-infected children in the community. J Infect Dis. 2000;181:966-974.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. Document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
5. Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal sero-groups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30:100-121. (Pubitemid 30067069)
6. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005;5:83-93.
7. Cohen R, Levy C, de La Rocque et al. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J. 2006;25:1001-1007.
8. Shouval DS, Greenberg D, Givon-Lavi N, et al. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J. 2009;28:277-282.
9. Leibovitz E, Petraru E, Porat N, et al. Antimicrobial susceptibility, serotype distribution and vaccine coverage of Streptococcus pneumoniae from invasive and mucosal diseases in children in Northeastern Romania. In: 5th World Congress of the World Society for Pediatric Infectious Diseases; November 15-18, 2007; Bangkok, Thailand. Abstract 0421.
10. Soriano F, Cafini F, Aguilar L, et al. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxome MICs of 16 mg/L and their genotypic and geographical relatedness. J Antimicrob Chemother. 2008;62:1234-1240.